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Endothelial vasoconstrictor prostanoids, vascular reactivity, and
acute renal failure. The interaction of endothelium-derived vaso-
constrictor prostaglandins, the angiotensins (Ang), and the sym-
pathetic nervous system in acute renal failure still remains to be
determined. In this study, acute renal failure (ARF) was induced
in male Wistar Kyoto rats (N 5 7) in a 2K/2C model of 30-minute
clamping. Contractions to Ang I and II and norepinephrine (NE)
were studied in isolated aortic and renal artery rings 24 hours after
clamp release. Sham-operated animals served as controls (N 5 7).
In ARF, contractions to NE were increased in the aorta and even
further enhanced in the renal artery (P , 0.05 to 0.001), whereas
contractions to Ang I and II were blunted (P , 0.05). Contrac-
tions were inhibited by SQ 30741, a thromboxane A2 (TXA2)/
prostaglandin H2 (PGH2) receptor antagonist. We conclude that
ARF is characterized by abnormal vascular reactivity both in the
renal as well as the systemic vasculature that is in part mediated by
endothelium-derived vasoconstrictor prostaglandins.
The pathophysiological concept of acute renal failure
(ARF) involves both tubular and vascular abnormalities
[1]. Vascular tone of blood vessels is regulated by the
sympathetic nervous system, hormones, such as angio-
tensins (Ang), and vasoactive substances produced by the
endothelium, such as metabolites of the cyclooxygenase
pathway, that is, thromboxane A2 (TXA2) and prostaglan-
din H2 (PGH2) [2]. Because renal vasoconstriction is the
hemodynamic hallmark of ischemic renal failure, this study
was designed to delineate further the interaction of neuro-
humoral factors, such as norepinephrine (NE) released
from sympathetic nerve endings, Ang, and endothelium-
derived prostanoids in vascular reactivity in ARF.
METHODS
Acute renal failure was induced in male Wistar Kyoto
rats (13 weeks old; Charles River, Sulzfeld, Germany) in a
2K/2C model by 30-minute clamping (N 5 7). Age-matched
animals that underwent sham operation (manipulation
of the renal pedicles) served as controls (CTL, N 5 7).
The rats were fed a standard chow (Nafag, Gossau,
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Fig. 1. Contractions to angiotensin (Ang) I in rat aortic and renal artery
rings. Contractions to Ang I (1027 M) were attenuated in acute renal
failure (ARF) in the aorta (N 5 7, P , 0.05 vs. control) and the renal
artery (N 5 7, P , 0.05 vs. control). Contractions were blunted by
SQ30741 in the renal artery (N 5 5, P , 0.05 vs. control), but not in the
aorta in ARF (N 5 5, n.s.).
Fig. 2. Contractions to angiotensin (Ang) II. In acute renal failure
(ARF), contractions to Ang II (1027 M) were diminished in the aorta (N 5
7, P , 0.05 vs. control) and the renal artery (N 5 7, P , 0.05 vs. control).
SQ30741 attenuated the response to Ang II in the renal artery (N 5 5, P ,
0.05 vs. control), but not in the aorta in ARF (N 5 5, n.s.).
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Switzerland). Systolic blood pressure was measured in
unanesthesized rats by the tail-cuff method (Blood Pres-
sure Recorder 8005; W1W, Mu¨nchenstein, Switzerland).
Animals were anesthetized (thiopental, 40 mg/kg body
weight, i.p.) 24 hours after clamp release, and the thoracic
aorta and renal artery were removed. Vessels were cut into
rings (length of 4 mm) and were placed in organ chambers
containing Krebs-Ringer bicarbonate solution. Rings were
repeatedly exposed to KCl (100 mM) until the optimal
resting tension was reached [aorta, 2.47 6 0.07 g (CTL),
2.45 6 0.04 g (ARF); renal artery, 1.48 6 0.08 g (CTL),
1.46 6 0.05 g (ARF)]. Cumulative concentration-response
curves to NE (10210-3 3 1025 M) were obtained in quies-
cent preparations. Because of the rapid development of
tachyphylaxis, only a single concentration (1027 M) of Ang
I or II was given. In some experiments, vascular rings were
incubated with SQ30741, a TXA2/PGH2 receptor antago-
nist (1027 M), and were then exposed to the agonist used.
Data are means 6 SEM for N animals. Concentrations
yielding 50% of the response to KCl (EC50 values ex-
pressed as negative logarithm, pD2) were calculated by
nonlinear regression analysis. For multiple comparisons,
data were analyzed with analysis of variance followed by
Bonferroni’s correction, and for simple comparison be-
tween two values, unpaired Student’s t-test was employed
when appropriate. P , 0.05 was considered significant.
RESULTS AND DISCUSSION
Creatinine clearance was reduced from 2.8 6 0.3 ml/min
to 0.2 6 0.2 ml/min (CTL, 2.7 6 0.2 ml/min to 2.5 6 0.3
ml/min). Systolic blood pressure and body weight did not
change significantly within 24 hours after clamp release.
Tissue weight of aortic (11.7 6 3.1 vs. 10.8 6 3.4 mg, n.s.)
and renal artery (11.2 6 2.1 vs. 10.8 6 2.2 mg, n.s.) rings did
not differ from CTLs.
In the aorta and the renal artery, contractions to KCl
(100 mM) did not differ significantly (aorta, 1120 6 189 mg
vs. 1089 6 210 mg, n.s.; renal artery, 782 6 145 mg vs. 752
6 129 mg, n.s.).
Contractions to Ang I (1027 M) were attenuated in ARF
in both aorta (N 5 7, P , 0.05 vs. CTL) and renal artery
(Fig. 1; N 5 7, P , 0.05 vs. CTL). Contractions were
blunted by SQ30741 in the renal artery (N 5 5, P , 0.05 vs.
CTL), but not in the aorta in ARF (Fig. 1; N 5 5, n.s.). In
ARF, contractions to Ang II (1027 M) were diminished in
both aorta (Fig. 2, N 5 7, P , 0.05 vs. CTL) and renal
artery (N 5 7, P , 0.05 vs. CTL). SQ30741 attenuated the
response to Ang II in the renal artery (Fig. 2, N 5 5, P ,
0.05 vs. CTL), but not in the aorta in ARF (N 5 5, n.s.).
The vascular response to NE (10211-3 3 1024 M) was
augmented in ARF in the aorta (Fig. 3; N 5 7, pD2, P 5
0.006 vs. CTL) and the renal artery (Fig. 3; N 5 7, pD2, P ,
0.05 vs. CTL). Contractions to NE were significantly atten-
uated by SQ30741 in the renal artery in ARF (Fig. 3; N 5
7, N 5 5, pD2, P , 0.05 vs. CTL). In the aorta, contractions
tended to be lower in SQ30741 pretreated rats in ARF, but
this trend did not reach statistical significance (Fig. 3; N 5
7, N 5 5, pD2, P 5 0.06 vs. CTL).
This study demonstrates that ARF is characterized by
abnormal vascular reactivity in the renal and the systemic
vasculatures. This is in part mediated by endothelium-
derived vasoconstrictor prostanoids. Responses to Ang I
and II decreased in the early phase of ARF, probably due
to activation of the renin-angiotensin system, leading to a
rapid down-regulation of Ang receptors in this animal
model of ischemic ARF. Moreover, contractions to Ang I
were less pronounced than those to the same concentra-
tions of Ang II, indicating diminished ACE activity in the
early phase in this model of ARF. Although contractions to
KCl, which directly depolarizes vascular smooth muscle,
Fig. 3. Contractions to norepinephrine (NE). Vascular response to NE (10211-3 3 1024 M) was augmented in acute renal failure (ARF) in the aorta
(left panel; N 5 7, pD2: P 5 0.006 vs. control) and the renal artery (right panel; N 5 7, pD2: P , 0.05 vs. control). Contractions to NE were significantly
attenuated by SQ30741 in the renal artery in ARF (left panel; N 5 7, N 5 5, pD2: P , 0.05 vs. control). In the aorta, contractions tended to be lower
in SQ30741 pretreated rats in ARF, but did not reach statistical significance (right panel; N 5 7, N 5 5, pD2: P 5 0.06 vs. control).
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were comparable in all groups, the vascular response to NE
was enhanced, indicating augmented sensitivity to a-adren-
ergic activation, both in the renal and systemic circulations.
Preincubation with a PGH2/TX receptor antagonist atten-
uated vasoconstriction to Ang I and II and NE in ARF,
indicating that an endothelium-derived constricting factor,
probably PGH2 and/or TXA2, mediates this response.
Abnormal vascular reactivity may thus be, at least in part,
attributable to increased sensitivity of the vascular smooth
muscle to vasoconstrictor prostaglandins. Indeed, Ang II
also enhances the release of vasoconstrictor prostanoids in
animal models of renovascular and ren-2 transgenic hyper-
tension [3, 4]. However, ischemic injury itself may increase
smooth muscle cytosolic calcium [5] and thereby facilitate
the effects to endogenous vasoconstrictors at the level of
the vascular smooth muscle. This may be particularly
relevant in conditions leading to renal ischemia; as such, an
augmented sensitivity to vasoconstrictor stimuli will in turn
increase the vulnerability of the affected organ to addi-
tional ischemic attacks.
In conclusion, the data show that augmented sensitivity
to a-adrenergic activation may be linked to the potentia-
tion of the response by endothelium-derived vasoconstric-
tor prostanoids.
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